[1] WORLD HEALTH ORGANIZATION.Global tuberculosis report 2021[EB/OL]. [2021-10-14]. https://www.who.int/publications/digital/global-tuberculosis-report-2021. [2] 卢春容,房宏霞,陆普选,等.2021 WHO全球结核病报告:全球与中国关键数据分析[J/CD].新发传染病电子杂志,2021,6(4):368-372. [3] CUI X, GAO L, CAO B.Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries[J]. Int J Infect Dis, 2020, 92s: S37-s40. [4] HONG BY, MAULéN NP, ADAMI AJ, et al. Microbiome Changes during Tuberculosis and Antituberculous Therapy[J]. Clin Microbiol Rev, 2016, 29(4): 915-926. [5] GOSENS R, HIEMSTRA PS, ADCOCK IM, et al.Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease[J]. Eur Respir J, 2020, 56(2). [6] 尤信信, 余卫业, 谭卫国, 等. 单细胞测序技术在结核病研究中的应用[J/CD]. 新发传染病电子杂志, 2017, 2(3): 151-154. [7] JOHANSSON I, WITKOWSKA E, KAVEH B, et al.The Microbiome in Populations with a Low and High Prevalence of Caries[J]. J Dent Res, 2016, 95(1): 80-86. [8] MATHIEU E, ESCRIBANO-VAZQUEZ U, DESCAMPS D, et al.Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma[J]. Front Physiol, 2018, 9: 1168. [9] FERNáNDEZ-BARAT L, LÓPEZ-ALADID R, TORRES A. Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome[J]. EBioMedicine, 2020, 60: 102995. [10] BARCIK W, BOUTIN RCT, SOKOLOWSKA M, et al.The Role of Lung and Gut Microbiota in the Pathology of Asthma[J]. Immunity, 2020, 52(2): 241-255. [11] TSAI YL, LIN TL, CHANG CJ, et al.Probiotics, prebiotics and amelioration of diseases[J]. J Biomed Sci, 2019, 26(1): 3. [12] ARMSTRONG GL, MACCANNELL DR, TAYLOR J, et al.Pathogen Genomics in Public Health[J]. N Engl J Med, 2019, 381(26): 2569-2580. [13] GOLLWITZER ES, MARSLAND BJ.Microbiota abnormalities in inflammatory airway diseases - Potential for therapy[J]. Pharmacol Ther, 2014, 141(1): 32-39. [14] GRIER A, MCDAVID A, WANG B, et al.Neonatal gut and respiratory microbiota: coordinated development through time and space[J]. Microbiome, 2018, 6(1): 193. [15] SHAH T, SHAH Z, BALOCH Z, et al.The role of microbiota in respiratory health and diseases, particularly in tuberculosis[J]. Biomed Pharmacother, 2021, 143: 112108. [16] WYPYCH TP, WICKRAMASINGHE LC, MARSLAND BJ.The influence of the microbiome on respiratory health[J]. Nat Immunol, 2019, 20(10): 1279-1290. [17] WANG H, YAO J, CHEN Y, et al. Gut dysbacteriosis attenuates resistance to Mycobacterium bovis infection by decreasing cyclooxygenase 2 to inhibit endoplasmic reticulum stress [J]. (2222-1751 (Electronic)). [18] KOH A, DE VADDER F, KOVATCHEVA-DATCHARY P, et al.From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites[J]. Cell, 2016, 165(6): 1332-1345. [19] ANTUNES KH, FACHI JL, DE PAULA R, et al.Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response[J]. Nat Commun, 2019, 10(1): 3273. [20] SEGAL LN, CLEMENTE JC, LI Y, et al. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients [J]. Cell Host Microbe, 2017, 21(4): 530-537.e534. [21] ERIBO OA, DU PLESSIS N, OZTURK M, et al.The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?[J]. Cell Mol Life Sci, 2020, 77(8): 1497-1509. [22] HU Y, YANG Q, LIU B, et al.Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs[J]. J Infect, 2019, 78(4): 317-322. [23] NAMASIVAYAM S, MAIGA M, YUAN W, et al.Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy[J]. Microbiome, 2017, 5(1): 71. [24] PALMA ALBORNOZ SP, FRAGA-SILVA TFC, GEMBRE AF, et al.Obesity-Induced Dysbiosis Exacerbates IFN-γ Production and Pulmonary Inflammation in the Mycobacterium tuberculosis Infection[J]. Cells, 2021, 10(7):1732. [25] BELL LCK, NOURSADEGHI M.Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection[J]. Nat Rev Microbiol, 2018, 16(2): 80-90. [26] PEARL JE, DAS M, COOPER AM.Immunological roulette: Luck or something more? Considering the connections between host and environment in TB[J]. Cell Mol Immunol, 2018, 15(3): 226-232. [27] SABEY KA, SONG SJ, JOLLES A, et al.Coinfection and infection duration shape how pathogens affect the African buffalo gut microbiota[J]. Isme j, 2021, 15(5): 1359-1371. [28] MCHARDY IH, LI X, TONG M, et al.HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota[J]. Microbiome, 2013, 1(1): 26. [29] 曹雨之, 王倩, 孟昱君, 等. 妊娠期糖尿病与肠道菌群改变的研究进展[J]. 中国临床新医学, 2022, 15(12): 1192-1197. [30] GUPTA A, KHANNA S.Fecal Microbiota Transplantation[J]. Jama, 2017, 318(1): 102. [31] OOIJEVAAR RE, TERVEER EM, VERSPAGET HW, et al.Clinical Application and Potential of Fecal Microbiota Transplantation[J]. Annu Rev Med, 2019, 70: 335-351. [32] KHAN N, VIDYARTHI A, NADEEM S, et al.Alteration in the Gut Microbiota Provokes Susceptibility to Tuberculosis[J]. Front Immunol, 2016, 7: 529. [33] WANG H, YAO J, CHEN Y, et al.Gut dysbacteriosis attenuates resistance to Mycobacterium bovis infection by decreasing cyclooxygenase 2 to inhibit endoplasmic reticulum stress[J]. Emerg Microbes Infect, 2022, 11(1): 1806-1818. [34] CUTHBERTSON L, WALKER AW, OLIVER AE, et al.Lung function and microbiota diversity in cystic fibrosis[J]. Microbiome, 2020, 8(1): 45. [35] DICKSON RP, ERB-DOWNWARD JR, FALKOWSKI NR, et al.The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity[J]. Am J Respir Crit Care Med, 2018, 198(4): 497-508. [36] COSTELLO SP, HUGHES PA, WATERS O, et al.Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial[J]. Jama, 2019, 321(2): 156-164. [37] 中华人民共和国国家卫生和计划生育委员会. 肺结核诊断标准(WS 288—2017) [J/CD]. 新发传染病电子杂志, 2018, 3(1): 59-61. |